0.5150
-0.0105
(-2.00%)
At close: January 30 at 3:29:02 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-81,841.0000
-55,173.0000
-78,093.0000
-90,728.0000
-78,209.0000
Investing Cash Flow
--
13,872.0000
13,170.0000
12,433.0000
-19,469.0000
Financing Cash Flow
143,251.0000
74,542.0000
27,692.0000
74,717.0000
136,294.0000
End Cash Position
98,867.0000
49,898.0000
16,657.0000
53,888.0000
57,466.0000
Issuance of Capital Stock
134,656.0000
64,514.0000
27,811.0000
74,421.0000
134,102.0000
Issuance of Debt
--
--
--
--
3,222.0000
Repayment of Debt
-776.0000
-1,858.0000
-3,273.0000
-4,718.0000
-2,148.0000
Free Cash Flow
-81,841.0000
-55,173.0000
-78,093.0000
-90,728.0000
-78,209.0000
12/31/2020 - 5/17/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3G0.BE Altimmune Inc
6.71
-0.52%
0M4.DU Mersana Therapeutics Inc
0.5906
+2.64%
AT20.F Atara Biotherapeutics, Inc.
7.45
-5.70%
1VT.DU Viking Therapeutics Inc
32.15
-1.20%
8AW0.F Ocean Biomedical, Inc.
0.2200
-34.91%
M55.F MacroGenics, Inc.
2.8940
-5.67%
8AW0.BE Ocean Biomedical Inc
0.1810
-23.31%
NV4.MU Cellectar Biosciences Inc
0.2420
-3.20%
NV4.F Cellectar Biosciences, Inc.
0.2000
-9.91%
LSRM.DU CEL-SCI Corp
0.3596
+2.74%